The inhibitory effect of intravenous d-tubocurarine and oral dantrolene on halothane-succinylcholine-induced myoglobinemia in children.
D000284:Administration, Oral; D000758:Anesthesia; D002648:Child; D002675:Child, Preschool; D003620:Dantrolene / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006221:Halothane / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009211:Myoglobin / Q000097:blood*; D013390:Succinylcholine / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D014403:Tubocurarine / Q000627:therapeutic use*
D009211:Myoglobin; D003620:Dantrolene; D013390:Succinylcholine; D006221:Halothane; D014403:Tubocurarine